Vol. 13. Núm. 18.
Páginas 993-999 (Octubre 2020)

Actualización
Diabetes insípida

Diabetes insipidus

E. Pascual-CorralesabM. Araujo-CastroabA.E. Ortiz-FloresabcH.F. Escobar-Morrealeabcd
Doi : https://10.1016/j.med.2020.10.001
Opciones
Resumen

La diabetes insípida es un trastorno poco común del metabolismo del agua, consecuencia de una acción deficitaria de hormona antidiurética. Esta puede deberse a un trastorno hipotalámico-hipofisario que impida su secreción (diabetes insípida central) o a la resistencia de los túbulos renales a la acción de esta hormona (diabetes insípida nefrogénica). La enfermedad se caracteriza por poliuria y polidipsia. El diagnóstico se confirma con la prueba de privación de agua, que pone de manifiesto la imposibilidad del riñón para concentrar la orina. El diagnóstico diferencial incluye situaciones como la eliminación de orina hipotónica secundaria al exceso de ingesta de líquido (polidipsia primaria) o la diuresis osmótica. La medición de concentraciones de vasopresina y la respuesta a la administración de desmopresina permiten diferenciar entre diabetes insípida central y nefrogénica. El tratamiento de la diabetes insípida central consiste en la administración de desmopresina, mientras que en la nefrogénica el tratamiento consiste en concentrar la médula renal mediante diuréticos (sobre todo tiazídicos) para facilitar la reabsorción de agua libre.

Palabras clave
Diabetes insípida
Hormona antidiurética
Poliuria
Vasopresina
Abstract

Diabetes insipidus: Diabetes insipidus is an uncommon disturbance in water metabolism resulting from a deficiency in the action of the antidiuretic hormone caused either by neurohypophyseal disorder difficulty its secretion (central diabetes insipidus) or by impaired renal response (nephrogenic diabetes insipidus). Clinically is characterized by polydipsia and polyuria. Water deprivation test, which assesses the ability of the kidney to concentrate urine, is the confirmatory diagnostic test. Differential diagnosis includes: primary polydipsia (hypotonic urination secondary to excessive fluid intake) and osmotic diuresis. In order to distinguish between central and nephrogenic diabetes insipidus, vasopressin levels and desmopressin response have to be assessed. Desmopressin is the treatment of central diabetes insipidus. On the other hand, and in order to facilitate kidney urine concentration, diuretic drugs (mainly thiazide diuretics) appear as the treatment of nephrogenic diabetes insipidus.

Keywords
Diabetes insipidus
Antidiuretic hormone
Polyuria
Vasopressin

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1]
M.
202010200627408848
202010200627408849
Fleseriu, I.A. Hashim, N. Karavitaki, S. Melmed, M.H. Murad, R. Salvatori, et al.
Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline.
J Clin Endocrinol Metab., (2016), 101 pp. 3888-3921
[2]
J.P.
2020102006274088410
Burbach, S.M. Luckman, D. Murphy, H. Gainer.
Gene regulation in the magnocellular hypothalamo-neurohypophysial system.
Physiol Rev., (2001), 81 pp. 1197-1267
[3]
M.
2020102006274088411
2020102006274088412
Christ-Crain, D.G. Bichet, W.K. Fenske, M.B. Goldman, S. Rittig, J.G. Verbalis, et al.
Diabetes insipidus.
Nat Rev Dis Primers., (2019), 5 pp. 54
[4]
M.
2020102006274088413
Maghnie, G. Cosi, E. Genovese, M.L. Manca-Bitti, A. Cohen, S. Zecca, et al.
Central diabetes insipidus in children and young adults.
N Engl J Med., (2000), 343 pp. 998-1007
[5]
W.
2020102006274088414
2020102006274088415
Fenske, B. Allolio.
Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review.
J Clin Endocrinol Metab., (2012), 97 pp. 3426-3437
[6]
J.A.
2020102006274088416
2020102006274088417
Loh, J.G. Verbalis.
Diabetes insipidus as a complication after pituitary surgery.
Nat Clin Pract Endocrinol Metab., (2007), 3 pp. 489-494
[7]
C.
2020102006274088418
2020102006274088419
Lamas, C. del Pozo, C. Villabona.
Clinical guidelines for management of diabetes insipidus and syndrome of inappropriate antidiuretic hormone secretion after pituitary surgery.
Endocrinol Nutr., (2014), 61 pp. e15-e24
[8]
P.A.
2020102006274088420
Singer, L.J. Sevilla.
Postoperative endocrine management of pituitary tumors.
Neurosurg Clin N Am., (2003), 14 pp. 123-138
[9]
J.
2020102006274088421
2020102006274088422
Hensen, A. Henig, R. Fahlbusch, M. Meyer, M. Boehnert, M. Buchfelder.
Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas.
Clin Endocrinol (Oxf)., (1999), 50 pp. 431-439
[10]
E.C.
2020102006274088423
2020102006274088424
Nemergut, Z. Zuo, J.A. Jane Jr., E.R. Laws Jr..
Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients.
J Neurosurg., (2005), 103 pp. 448-454
[11]
H.
2020102006274088425
Imura, K. Nakao, A. Shimatsu, Y. Ogawa, T. Sando, I. Fujisawa, et al.
Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus.
N Engl J Med., (1993), 329 pp. 683-689
[12]
J.F.
2020102006274088426
McLeod, L. Kovacs, M.B. Gaskill, S. Rittig, G.S. Bradley, G.L. Robertson.
Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation.
J Clin Endocrinol Metab., (1993), 77 pp. 599A-G
[13]
S.
2020102006274088427
Rittig, G.L. Robertson, C. Siggaard, L. Kovacs, N. Gregersen, J. Nyborg, et al.
Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.
Am J Hum Genet., (1996), 58 pp. 107-117
[14]
M.D.
2020102006274088428
Willcutts, E. Felner, P.C. White.
Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.
Hum Mol Genet., (1999), 8 pp. 1303-1307
[15]
A.
2020102006274088429
Abu Libdeh, F. Levy-Khademi, M. Abdulhadi-Atwan, E. Bosin, M. Korner, P.C. White, et al.
Autosomal recessive familial neurohypophyseal diabetes insipidus: onset in early infancy.
Eur J Endocrinol., (2010), 162 pp. 221-226
[16]
R.
2020102006274088430
Habiby, G.L. Robertson, P.B. Kaplowitz, S. Rittig.
A novel X-linked form of familial neurohypophyseal diabetes insipidus.
J Invest Med., (1996), 44 pp. 341A
[17]
T.G.
2020102006274088431
Barrett, S.E. Bundey.
Wolfram (DIDMOAD) syndrome.
J Med Genet., (1997), 34 pp. 838-841
[18]
R.
2020102006274088432
2020102006274088433
Boton, M. Gaviria, D.C. Batlle.
Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy.
Am J Kidney Dis., (1987), 10 pp. 329-345
[19]
H.
2020102006274088434
2020102006274088435
Bendz, M. Aurell.
Drug-induced diabetes insipidus: incidence, prevention and management.
[20]
D.
2020102006274088436
2020102006274088437
Marples, S. Christensen, E.I. Christensen, P.D. Ottosen, S. Nielsen.
Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla.
J Clin Invest., (1995), 95 pp. 1838-1845
[21]
G.S.
2020102006274088438
Markowitz, J. Radhakrishnan, N. Kambham, A.M. Valeri, W.H. Hines, V.D. D’Agati.
Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy.
J Am Soc Nephrol., (2000), 11 pp. 1439-1448
[22]
H.
2020102006274088439
Bendz, I. Sjodin, M. Aurell.
Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study.
Nephrol Dial Transplant., (1996), 11 pp. 457-460
[23]
D.
2020102006274088440
Marples, J. Frokiaer, J. Dorup, M.A. Knepper, S. Nielsen.
Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex.
J Clin Invest., (1996), 97 pp. 1960-1968
[24]
J.M.
2020102006274088441
Sands, F.X. Flores, A. Kato, M.A. Baum, E.M. Brown, D.T. Ward, et al.
Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats.
Am J Physiol., (1998), 274 pp. F978-F985
[25]
T.M.
2020102006274088442
Fujiwara, D.G. Bichet.
Molecular biology of hereditary diabetes insipidus.
J Am Soc Nephrol., (2005), 16 pp. 2836-2846
[26]
Y.
2020102006274088443
2020102006274088444
Iwasaki, Y. Oiso, K. Kondo, S. Takagi, K. Takatsuki, H. Hasegawa, et al.
Aggravation of subclinical diabetes insipidus during pregnancy.
N Engl J Med., (1991), 324 pp. 522-526
[27]
G.L.
2020102006274088445
2020102006274088446
Robertson.
Dipsogenic diabetes insipidus: a newly recognized syndrome caused by a selective defect in the osmoregulation of thirst.
Trans Assoc Am Physicians., (1987), 100 pp. 241-249
[28]
M.B.
2020102006274088447
2020102006274088448
Goldman, D.J. Luchins, G.L. Robertson.
Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia.
N Engl J Med., (1988), 318 pp. 397-403
[29]
J.
2020102006274088449
2020102006274088450
de Leon, C. Verghese, J.I. Tracy, R.C. Josiassen, G.M. Simpson.
Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature.
Biol Psychiatry., (1994), 35 pp. 408-419
[30]
J.G.
2020102006274088451
2020102006274088452
Verbalis.
Disorders of body water homeostasis.
Best Pract Res Clin Endocrinol Metab., (2003), 17 pp. 471-503
[31]
P.W.
2020102006274088453
Rogers, N.A. Kurtzman.
Renal failure, uncontrollable thirst, and hyperreninemia.
Cessation of thirst with bilateral nephrectomy. JAMA., (1973), 225 pp. 1236-1238
[32]
M.
2020102006274088454
Miller, T. Dalakos, A.M. Moses, H. Fellerman, D.H. Streeten.
Recognition of partial defects in antidiuretic hormone secretion.
Ann Intern Med., (1970), 73 pp. 721-729
[33]
W.
2020102006274088455
2020102006274088456
Pedrosa, J.B. Drummond, B.S. Soares, A. Ribeiro-Oliveira Jr..
A combined outpatient and inpatient overnight water deprivation test is effective and safe in diagnosing patients with polyuria-polydipsia syndrome.
Endocr Pract., (2018), 24 pp. 963-972
[34]
K.
2020102006274088457
2020102006274088458
Timper, W. Fenske, F. Kuhn, N. Frech, B. Arici, J. Rutishauser, et al.
Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study.
J Clin Endocrinol Metab., (2015), 100 pp. 2268-2274
[35]
I.
2020102006274088459
Fujisawa, R. Asato, K. Nishimura, K. Togashi, K. Itoh, Y. Nakano, et al.
Anterior and posterior lobes of the pituitary gland: assessment by 1.5T MR imaging.
J Comput Assist Tomogr., (1987), 11 pp. 214-220
[36]
A.M.
2020102006274088460
Moses, B. Clayton, L. Hochhauser.
Use of T1-weighted MR imaging to differentiate between primary polydipsia and central diabetes insipidus.
AJNR Am J Neuroradiol., (1992), 13 pp. 1273-1277
[37]
M.
2020102006274088461
Maghnie, E. Genovese, S. Bernasconi, S. Binda, M. Arico.
Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus.
AJNR Am J Neuroradiol., (1997), 18 pp. 1749-1752
[38]
B.S.
2020102006274088462
Brooks, T. el Gammal, J.D. Allison, W.H. Hoffman.
Frequency and variation of the posterior pituitary bright signal on MR images.
AJR Am J Roentgenol., (1989), 153 pp. 1033-1038
[39]
M.
2020102006274088463
Maghnie, A. Villa, M. Arico, D. Larizza, S. Pezzotta, G. Beluffi, et al.
Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus.
J Clin Endocrinol Metab., (1992), 74 pp. 795-800
[40]
J.
2020102006274088464
Leger, A. Velasquez, C. Garel, M. Hassan, P. Czernichow.
Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.
J Clin Endocrinol Metab., (1999), 84 pp. 1954-1960